 | Up a level |
Pavlovic, Blaz; Bräutigam, Konstantin; Dartiguenave, Florence; Martel, Paul; Rakauskas, Arnas; Cesson, Valérie; Veit, Markus; Oechslin, Pascal; Gu, Alexander; Hermanns, Thomas; Saba, Karim; Poyet, Cédric; Hötker, Andreas M; Rupp, Niels J; Valerio, Massimo; Derré, Laurent; Eberli, Daniel; Banzola, Irina (2024). Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy. Scientific Reports, 14(18148) Nature Publishing Group 10.1038/s41598-024-68026-1
Voskuilen, Charlotte S; Seiler, Roland; Rink, Michael; Poyet, Cédric; Noon, Aidan P; Roghmann, Florian; Necchi, Andrea; Aziz, Atiqullah; Lavollé, Alexandre; Young, Matthew J; Marks, Phillip; Saba, Karim; van Rhijn, Bas W G; Fransen van de Putte, Elisabeth E; Ablat, Jason; Black, Peter C; Sosnowski, Roman; Dobruch, Jakub; Kumar, Pardeep; Jallad, Samer; ... (2020). Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes. European urology focus, 6(6), pp. 1226-1232. Elsevier 10.1016/j.euf.2018.12.002
Voskuilen, Charlotte S; Oo, Htoo Zarni; Genitsch Gratwohl, Vera; Smit, Laura A; Vidal, Alvaro; Meneses, Manuel; Necchi, Andrea; Colecchia, Maurizio; Xylinas, Evanguelos; Fontugne, Jacqueline; Sibony, Mathilde; Rouprêt, Morgan; Lenfant, Louis; Côté, Jean-François; Buser, Lorenz; Saba, Karim; Furrer, Marc A.; van der Heijden, Michiel S; Daugaard, Mads; Black, Peter C; ... (2019). Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Carcinoma. The American journal of surgical pathology, 43(12), pp. 1600-1610. Lippincott Williams & Wilkins 10.1097/PAS.0000000000001371
von Landenberg, Nicolas; Aziz, Atiqullah; von Rundstedt, Friedrich C; Dobruch, Jakub; Kluth, Luis A; Necchi, Andrea; Noon, Aidan; Rink, Michael; Hendricksen, Kees; Decaestecker, Karel P J; Seiler, Roland; Poyet, Cédric; Fajkovic, Harun; Shariat, Shahrokh F; Xylinas, Evanguelos; Roghmann, Florian (2018). Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancer. Urologic oncology - seminars and original investigations, 36(5), 238.e19-238.e27. Elsevier 10.1016/j.urolonc.2018.01.017
